A NOTCH4 missense mutation confers resistance to multiple sclerosis in Japanese

Multiple Sclerosis Journal

Volumn 19, Issue 13, 2013, Pages 1696-1703

  Huang, Jian ^a   Yoshimura, Satoshi ^a   Isobe, Noriko ^a   Matsushita, Takuya ^a   Yonekawa, Tomomi ^a   Sato, Shinya ^a   Yamasaki, Ryo ^a   Kira, Jun Ichi ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

genetics; human leukocyte antigen; Multiple sclerosis; NOTCH4; polymorphism

Indexed keywords

AQUAPORIN 4 ANTIBODY; HLA DRB1 ANTIGEN; NOTCH4 RECEPTOR;

ADULT; ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE DURATION; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HAPLOTYPE; HLA TYPING; HUMAN; HUMAN CELL; JAPANESE; MAJOR CLINICAL STUDY; MALE; MISSENSE MUTATION; MULTIPLE SCLEROSIS; MYELOOPTIC NEUROPATHY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; POLYMERASE CHAIN REACTION; RELAPSE; SPINAL CORD LESION;

GENETICS; HUMAN LEUKOCYTE ANTIGEN; MULTIPLE SCLEROSIS; NOTCH4; POLYMORPHISM;

ALLELES; AQUAPORIN 4; CONFIDENCE INTERVALS; DISEASE RESISTANCE; DNA; FEMALE; GENE FREQUENCY; GENOTYPE; HAPLOTYPES; HLA-DRB1 CHAINS; HUMANS; JAPAN; LINKAGE DISEQUILIBRIUM; LOGISTIC MODELS; MALE; MULTIPLE SCLEROSIS; MUTATION, MISSENSE; NEUROMYELITIS OPTICA; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTO-ONCOGENE PROTEINS; RECEPTORS, DOPAMINE D1; RECEPTORS, NOTCH;

EID: 84883354784     PISSN: 13524585     EISSN: 14770970     Source Type: Journal    
DOI: 10.1177/1352458513482512     Document Type: Article

References (41)

1. Stadelmann C, Wegner C, Brück W. Inflammation, demyelination, and degeneration - recent insights from MS pathology. Biochim Biophys Acta. 2011 ; 1812: 275-282
2. Ramagopalan SV, Ebers GC. Genes for multiple sclerosis. Lancet. 2008 ; 371: 283-285
3. Nischwitz S, Müller-Myhsok B, Weber F. Risk conferring genes in multiple sclerosis. FEBS Lett. 2011 ; 585: 3789-3797
4. Marrosu MG, Murru MR, Costa G, et al. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population. Hum Mol Genet. 1998 ; 7: 1235-1237
5. Marrosu MG, Sardu C, Cocco E, et al. Bias in parental transmission of the HLA-DR3 allele in Sardinian multiple sclerosis. Neurology. 2004 ; 63: 1084-1086
6. The genetic association of variants in CD6, TNFRSF1A and IRF8 to multiple sclerosis: A multicenter case-control study. PLoS One. 2011 ; 6: e18813
7. Sawcer S, et al. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature. 2011 ; 476: 214-219
8. Kira J. Multiple sclerosis in the Japanese population. Lancet Neurol. 2003 ; 2: 117-127
9. Yamasaki K, Horiuchi I, Minohara M, et al. HLA-DPB1*0501-associated opticospinal multiple sclerosis: Clinical, neuroimaging and immunogenetic studies. Brain. 1999 ; 122: 1689-1696
10. Kira J. Neuromyelitis optica and Asian phenotype of multiple sclerosis. Ann N Y Acad Sci. 2008 ; 1142: 58-71
11. Yoshimura S, Isobe N, Matsushita T, et al. Distinct genetic and infectious profiles in Japanese neuromyelitis optica patients according to anti-aquaporin 4 antibody status. J Neurol Neurosurg Psychiatry. 2013 ; 84: 29-34
12. Yoshimura S, Isobe N, Yonekawa T, et al. Genetic and infectious profiles of Japanese multiple sclerosis patients. PLoS One. 2012 ; 7: e48592
13. Dyment DA, Herrera BM, Cader MZ, et al. Complex interactions among MHC haplotypes in multiple sclerosis: Susceptibility and resistance. Hum Mol Genet. 2005 ; 14: 2019-2026
14. Barcellos LF, Sawcer S, Ramsay PP, et al. Heterogeneity at the HLA-DRB1 locus and risk for multiple sclerosis. Hum Mol Genet. 2006 ; 15: 2813-2824
15. Ramagopalan SV, Morris AP, Dyment DA, et al. The inheritance of resistance alleles in multiple sclerosis. PLoS Genet. 2007 ; 3: 1607-1613
16. Zhang Q, Lin CY, Dong Q, et al. Relationship between HLA-DRB1 polymorphism and susceptibility or resistance to multiple sclerosis in Caucasians: A meta-analysis of non-family-based studies. Autoimmun Rev. 2011 ; 10: 474-481
17. Laaksonen M, Pastinen T, Sjöroos M, et al. HLA class II associated risk and protection against multiple sclerosis-a Finnish family study. J Neuroimmunol. 2002 ; 122: 140-145
18. Haegert DG, Swift FV, Benedikz J. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland. Neurology. 1996 ; 46: 1107-1111
19. Masterman T, Ligers A, Olsson T, et al. HLA-DR15 is associated with lower age at onset in multiple sclerosis. Ann Neurol. 2000 ; 48: 211-219
20. Luomala M, Elovaara I, Ukkonen M, et al. The combination of HLA-DR1 and HLA-DR53 protects against MS. Neurology. 2001 ; 56: 383-385
21. Ballerini C, Guerini FR, Rombolà G, et al. HLA-multiple sclerosis association in continental Italy and correlation with disease prevalence in Europe. J Neuroimmunol. 2004 ; 150: 178-185
22. Kira J, Kanai T, Nishimura Y, et al. Western versus Asian types of multiple sclerosis: Immunogenetically and clinically distinct disorders. Ann Neurol. 1996 ; 40: 569-574
23. Matsuoka T, Matsushita T, Osoegawa M, et al. Association of the HLA-DRB1 alleles with characteristic MRI features of Asian multiple sclerosis. Mult Scler. 2008 ; 14: 1181-1190
24. Isobe N, Matsushita T, Yamasaki R, et al. Influence of HLA-DRB1 alleles on the susceptibility and resistance to multiple sclerosis in Japanese patients with respect to anti-aquaporin 4 antibody status. Mult Scler. 2010 ; 16: 147-155
25. Qiu W, James I, Carroll WM, et al. HLA-DR allele polymorphism and multiple sclerosis in Chinese populations: A meta-analysis. Mult Scler. 2011 ; 17: 382-388
26. McElroy JP, Isobe N, Gourraud PA, et al. SNP-based analysis of the HLA locus in Japanese multiple sclerosis patients. Genes Immun. 2011 ; 12: 523-530
27. Duvefelt K, Anderson M, Fogdell-Hahn A, et al. A NOTCH4 association with multiple sclerosis is secondary to HLA-DR*1501. Tissue Antigens. 2004 ; 63: 13-20
28. Gridley T.. Notch signaling in vascular development and physiology. Development. 2007 ; 134: 2709-2718
29. Uyttendaele H, Marazzi G, Wu G, et al. Notch4/int-3, a mammary proto-oncogene, is an endothelial cell-specific mammalian Notch gene. Development. 1996 ; 122: 2251-2259
30. Uyttendaele H, Ho J, Rossant J, et al. Vascular patterning defects associated with expression of activated Notch4 in embryonic endothelium. Proc Natl Acad Sci U S A. 2001 ; 98: 5643-5648
31. Leong KG, Hu X, Li L, et al. Activated Notch4 inhibits angiogenesis: Role of beta 1-integrin activation. Mol Cell Biol. 2002 ; 22: 2830-2841
32. Krebs LT, Xue Y, Norton CR, et al. Notch signaling is essential for vascular morphogenesis in mice. Genes Dev. 2000 ; 14: 1343-1352
33. Wingerchuk DM, Lennon VA, Pittock SJ, et al. Revised diagnostic criteria for neuromyelitis optica. Neurology. 2006 ; 66: 1485-1489
34. Polman CH, Reingold SC, Edan G, et al. Diagnostic criteria for multiple sclerosis: 2005 revisions to the 'McDonald Criteria'. Ann Neurol. 2005 ; 58: 840-846
35. Nakashima I, Fujihara K, Sato S, et al. Oligoclonal IgG bands in Japanese patients with multiple sclerosis. A comparative study between isoelectric focusing with IgG immunofixation and high-resolution agarose gel electrophoresis. J Neuroimmunol. 2005 ; 159: 133-136
36. Matsushita T, Matsuoka T, Isobe N, et al. Association of the HLA-DPB1*0501 allele with anti-aquaporin-4 antibody positivity in Japanese patients with idiopathic central nervous system demyelinating disorders. Tissue Antigens. 2009 ; 73: 171-176
37. Barkhof F, Filippi M, Miller DH, et al. Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain. 1997 ; 120: 2059-2069
38. Wilhelm I, Fazakas C, Krizbai IA. In vitro models of the blood-brain barrier. Acta Neurobiol Exp (Wars). 2011 ; 71: 113-128
39. Li F, Lan Y, Wang Y, et al. Endothelial Smad4 maintains cerebrovascular integrity by activating N-cadherin through cooperation with Notch. Dev Cell. 2011 ; 20: 291-302
40. Li L, Huang GM, Banta AB, et al. Cloning, characterization, and the complete 56.8-kilobase DNA sequence of the human NOTCH4 gene. Genomics. 1998 ; 51: 45-58
41. Scott AP, Laing NG, Mastaglia F, et al. Investigation of NOTCH4 coding region polymorphisms in sporadic inclusion body myositis. J Neuroimmunol. 2012 ; 250: 66-70